Erytech Pharma SA is a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases. Its ERYCAPS platform, uses a novel technology to encapsulate therapeutic drug substances inside erythrocytes, or red blood cells, or RBC. It is developing a... Erytech Pharma SA is a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases. Its ERYCAPS platform, uses a novel technology to encapsulate therapeutic drug substances inside erythrocytes, or red blood cells, or RBC. It is developing a pipeline of product candidates for patients with high unmet medical needs. Its lead product candidate eryaspase, also referred as GRASPA, targets the metabolism of cancer cells by depriving the cells of asparagine, an amino acid necessary for their survival and critical in maintaining the cells' rapid growth rate. Show more
A French biotech company is making some major waves so far during Tuesday’s session after it was announced that the company and Pherecydes intend to merge their operations To read the full...
By Chris Wack Erytech Pharma SA shares were down 19%, to $1 after the company said it is no longer seeking approval for Graspa in hypersensitive acute lymphoblastic leukemia following feedback...
LYON, France, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French AutoritΓ© des MarchΓ©s Financiers Lyon β France Listing markets: Euronext Paris from Euronext...
LYON, France, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Β Article 223-16 of general regulation of French AutoritΓ© des MarchΓ©s FinanciersLyon β France Listing markets: Euronext Paris from Euronext...
LYON, France, July 10, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French AutoritΓ© des MarchΓ©s Financiers Lyon β France Listing markets: Euronext Paris from Euronext...
LYON, France, June 09, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French AutoritΓ© des MarchΓ©s FinanciersLyon β France Listing markets: Euronext Paris from Euronext...
LYON, France, May 07, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French AutoritΓ© des MarchΓ©s FinanciersLyon β France Listing markets: Euronext Paris from Euronext (Market...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.